APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Allergy Immunotherapy

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

Selected research

Industry Growth & Trends

Global Allergy Immunotherapy Industry Growth and Trends Forecast to 2032

Report ID 173896560121 December 202596 pages

Choose your research edition.

Industry ResearchAllergy Immunotherapy Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Allergy Immunotherapy Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Allergy Immunotherapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allergy Immunotherapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Allergy Immunotherapy Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.

In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Allergy Immunotherapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Allergy Immunotherapy market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Allergy Immunotherapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Allergy Immunotherapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Allergy Immunotherapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Allergy Immunotherapy Market by Company

ALK-Abello

Stallergenes Greer

Merck

Allergy Therapeutics

HAL

Holister Stier

Leti

Allergy Immunotherapy Segment by Type

Subcutaneous Immunotherapy

Sublingual Immunotherapy

Allergy Immunotherapy Segment by Application

Allergic Rhinitis

Allergic Asthma

Others

Allergy Immunotherapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Allergy Immunotherapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Allergy Immunotherapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Subcutaneous Immunotherapy Table 2. Major Company of Sublingual Immunotherapy Table 3. Global Allergy Immunotherapy Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Allergy Immunotherapy Sales by Type (2021-2026) & (K Units) Table 5. Global Allergy Immunotherapy Sales Market Share in Volume by Type (2021-2026) Table 6. Global Allergy Immunotherapy Sales by Type (2021-2026) & (US$ Million) Table 7. Global Allergy Immunotherapy Sales Market Share in Value by Type (2021-2026) Table 8. Global Allergy Immunotherapy Price by Type (2021-2026) & (USD/Unit) Table 9. Global Allergy Immunotherapy Sales by Type (2027-2032) & (K Units) Table 10. Global Allergy Immunotherapy Sales Market Share in Volume by Type (2027-2032) Table 11. Global Allergy Immunotherapy Sales by Type (2027-2032) & (US$ Million) Table 12. Global Allergy Immunotherapy Sales Market Share in Value by Type (2027-2032) Table 13. Global Allergy Immunotherapy Price by Type (2027-2032) & (USD/Unit) Table 14. North America Allergy Immunotherapy Sales by Type (2021-2026) & (K Units) Table 15. North America Allergy Immunotherapy Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Allergy Immunotherapy Sales by Type (2021-2026) & (K Units) Table 17. Europe Allergy Immunotherapy Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Allergy Immunotherapy Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Allergy Immunotherapy Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Allergy Immunotherapy Sales by Type (2021-2026) & (K Units) Table 21. Latin America Allergy Immunotherapy Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Allergy Immunotherapy Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Allergy Immunotherapy Sales by Type (2021-2026) & (US$ Million) Table 24. Allergy Immunotherapy Industry Trends Table 25. Allergy Immunotherapy Industry Drivers Table 26. Allergy Immunotherapy Industry Opportunities and Challenges Table 27. Allergy Immunotherapy Industry Restraints Table 28. Global Allergy Immunotherapy Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Allergy Immunotherapy Revenue Market Share by Company (2021-2026) Table 30. Global Allergy Immunotherapy Sales by Company (2021-2026) & (K Units) Table 31. Global Allergy Immunotherapy Sales Share by Company (2021-2026) Table 32. Global Allergy Immunotherapy Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Allergy Immunotherapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Allergy Immunotherapy Major Company Production Sites and Headquarters Table 35. Global Allergy Immunotherapy Company, Product Type & Application Table 36. Global Allergy Immunotherapy Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Allergy Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Allergy Immunotherapy Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Allergy Immunotherapy Sales by Region (2021-2026) & (K Units) Table 41. Global Allergy Immunotherapy Sales Market Share in Volume by Region (2021-2026) Table 42. Global Allergy Immunotherapy Sales by Region (2021-2026) & (US$ Million) Table 43. Global Allergy Immunotherapy Sales Market Share in Value by Region (2021-2026) Table 44. Global Allergy Immunotherapy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Allergy Immunotherapy Sales by Region (2027-2032) & (K Units) Table 46. Global Allergy Immunotherapy Sales Market Share in Volume by Region (2027-2032) Table 47. Global Allergy Immunotherapy Sales by Region (2027-2032) & (US$ Million) Table 48. Global Allergy Immunotherapy Sales Market Share in Value by Region (2027-2032) Table 49. Global Allergy Immunotherapy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Allergy Immunotherapy Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Allergy Immunotherapy Sales by Application (2021-2026) & (K Units) Table 52. Global Allergy Immunotherapy Sales Market Share in Volume by Application (2021-2026) Table 53. Global Allergy Immunotherapy Sales by Application (2021-2026) & (US$ Million) Table 54. Global Allergy Immunotherapy Sales Market Share in Value by Application (2021-2026) Table 55. Global Allergy Immunotherapy Price by Application (2021-2026) & (USD/Unit) Table 56. Global Allergy Immunotherapy Sales by Application (2027-2032) & (K Units) Table 57. Global Allergy Immunotherapy Sales Market Share in Volume by Application (2027-2032) Table 58. Global Allergy Immunotherapy Sales by Application (2027-2032) & (US$ Million) Table 59. Global Allergy Immunotherapy Sales Market Share in Value by Application (2027-2032) Table 60. Global Allergy Immunotherapy Price by Application (2027-2032) & (USD/Unit) Table 61. North America Allergy Immunotherapy Sales by Application (2021-2026) & (K Units) Table 62. North America Allergy Immunotherapy Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Allergy Immunotherapy Sales by Application (2021-2026) & (K Units) Table 64. Europe Allergy Immunotherapy Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Allergy Immunotherapy Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Allergy Immunotherapy Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Allergy Immunotherapy Sales by Application (2021-2026) & (K Units) Table 68. Latin America Allergy Immunotherapy Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Allergy Immunotherapy Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Allergy Immunotherapy Sales by Application (2021-2026) & (US$ Million) Table 71. ALK-Abello Company Information Table 72. ALK-Abello Business Overview Table 73. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. ALK-Abello Allergy Immunotherapy Product Portfolio Table 75. ALK-Abello Recent Development Table 76. Stallergenes Greer Company Information Table 77. Stallergenes Greer Business Overview Table 78. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Stallergenes Greer Allergy Immunotherapy Product Portfolio Table 80. Stallergenes Greer Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Merck Allergy Immunotherapy Product Portfolio Table 85. Merck Recent Development Table 86. Allergy Therapeutics Company Information Table 87. Allergy Therapeutics Business Overview Table 88. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Allergy Therapeutics Allergy Immunotherapy Product Portfolio Table 90. Allergy Therapeutics Recent Development Table 91. HAL Company Information Table 92. HAL Business Overview Table 93. HAL Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. HAL Allergy Immunotherapy Product Portfolio Table 95. HAL Recent Development Table 96. Holister Stier Company Information Table 97. Holister Stier Business Overview Table 98. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Holister Stier Allergy Immunotherapy Product Portfolio Table 100. Holister Stier Recent Development Table 101. Leti Company Information Table 102. Leti Business Overview Table 103. Leti Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Leti Allergy Immunotherapy Product Portfolio Table 105. Leti Recent Development Table 106. North America Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 107. North America Allergy Immunotherapy Sales by Country (2021-2026) & (K Units) Table 108. North America Allergy Immunotherapy Sales Market Share by Country (2021-2026) Table 109. North America Allergy Immunotherapy Sales Forecast by Country (2027-2032) & (K Units) Table 110. North America Allergy Immunotherapy Sales Market Share Forecast by Country (2027-2032) Table 111. North America Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. North America Allergy Immunotherapy Market Size by Country (2021-2026) & (US$ Million) Table 113. North America Allergy Immunotherapy Market Share by Country (2021-2026) Table 114. North America Allergy Immunotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. North America Allergy Immunotherapy Market Share Forecast by Country (2027-2032) Table 116. Europe Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 117. Europe Allergy Immunotherapy Sales by Country (2021-2026) & (K Units) Table 118. Europe Allergy Immunotherapy Sales Market Share by Country (2021-2026) Table 119. Europe Allergy Immunotherapy Sales Forecast by Country (2027-2032) & (K Units) Table 120. Europe Allergy Immunotherapy Sales Market Share Forecast by Country (2027-2032) Table 121. Europe Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Europe Allergy Immunotherapy Market Size by Country (2021-2026) & (US$ Million) Table 123. Europe Allergy Immunotherapy Market Share by Country (2021-2026) Table 124. Europe Allergy Immunotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Europe Allergy Immunotherapy Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Allergy Immunotherapy Sales by Country (2021-2026) & (K Units) Table 128. Asia-Pacific Allergy Immunotherapy Sales Market Share by Country (2021-2026) Table 129. Asia-Pacific Allergy Immunotherapy Sales Forecast by Country (2027-2032) & (K Units) Table 130. Asia-Pacific Allergy Immunotherapy Sales Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Allergy Immunotherapy Market Size by Country (2021-2026) & (US$ Million) Table 133. Asia-Pacific Allergy Immunotherapy Market Share by Country (2021-2026) Table 134. Asia-Pacific Allergy Immunotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Asia-Pacific Allergy Immunotherapy Market Share Forecast by Country (2027-2032) Table 136. Latin America Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Latin America Allergy Immunotherapy Sales by Country (2021-2026) & (K Units) Table 138. Latin America Allergy Immunotherapy Sales Market Share by Country (2021-2026) Table 139. Latin America Allergy Immunotherapy Sales Forecast by Country (2027-2032) & (K Units) Table 140. Latin America Allergy Immunotherapy Sales Market Share Forecast by Country (2027-2032) Table 141. Latin America Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Latin America Allergy Immunotherapy Market Size by Country (2021-2026) & (US$ Million) Table 143. Latin America Allergy Immunotherapy Market Share by Country (2021-2026) Table 144. Latin America Allergy Immunotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Latin America Allergy Immunotherapy Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Allergy Immunotherapy Sales by Country (2021-2026) & (K Units) Table 148. Middle East and Africa Allergy Immunotherapy Sales Market Share by Country (2021-2026) Table 149. Middle East and Africa Allergy Immunotherapy Sales Forecast by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Allergy Immunotherapy Sales Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Allergy Immunotherapy Market Size by Country (2021-2026) & (US$ Million) Table 153. Middle East and Africa Allergy Immunotherapy Market Share by Country (2021-2026) Table 154. Middle East and Africa Allergy Immunotherapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Middle East and Africa Allergy Immunotherapy Market Share Forecast by Country (2027-2032) Table 156. Key Raw Materials Table 157. Raw Materials Key Suppliers Table 158. Allergy Immunotherapy Distributors List Table 159. Allergy Immunotherapy Customers List Table 160. Research Programs/Design for This Report Table 161. Authors List of This Report Table 162. Secondary Sources Table 163. Primary Sources List of Figures Figure 1. Allergy Immunotherapy Image Figure 2. Global Allergy Immunotherapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allergy Immunotherapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Allergy Immunotherapy Sales (2021-2032) & (K Units) Figure 5. Subcutaneous Immunotherapy Image Figure 6. Global Subcutaneous Immunotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 7. Sublingual Immunotherapy Image Figure 8. Global Sublingual Immunotherapy Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Allergy Immunotherapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Allergy Immunotherapy Market Share by Type 2025 VS 2032 Figure 11. North America Allergy Immunotherapy Sales Market Share in Volume by Type in 2025 Figure 12. North America Allergy Immunotherapy Sales Market Share in Value by Type in 2025 Figure 13. Europe Allergy Immunotherapy Sales Market Share in Volume by Type in 2025 Figure 14. Europe Allergy Immunotherapy Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Allergy Immunotherapy Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Allergy Immunotherapy Sales Market Share in Value by Type in 2025 Figure 17. Latin America Allergy Immunotherapy Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Allergy Immunotherapy Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Allergy Immunotherapy Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Allergy Immunotherapy Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Allergy Immunotherapy Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Allergic Rhinitis Image Figure 24. Global Allergic Rhinitis Sales YoY Growth (2021-2032) & (K Units) Figure 25. Allergic Asthma Image Figure 26. Global Allergic Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Allergy Immunotherapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Allergy Immunotherapy Market Share by Application 2025 VS 2032 Figure 31. North America Allergy Immunotherapy Sales Market Share in Volume by Application in 2025 Figure 32. North America Allergy Immunotherapy Sales Market Share in Value by Application in 2025 Figure 33. Europe Allergy Immunotherapy Sales Market Share in Volume by Application in 2025 Figure 34. Europe Allergy Immunotherapy Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Allergy Immunotherapy Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Allergy Immunotherapy Sales Market Share in Value by Application in 2025 Figure 37. Latin America Allergy Immunotherapy Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Allergy Immunotherapy Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Allergy Immunotherapy Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Allergy Immunotherapy Sales Market Share in Value by Application in 2025 Figure 41. North America Allergy Immunotherapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Allergy Immunotherapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Allergy Immunotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Allergy Immunotherapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Allergy Immunotherapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Allergy Immunotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Allergy Immunotherapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Allergy Immunotherapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Allergy Immunotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Allergy Immunotherapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Allergy Immunotherapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Allergy Immunotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Allergy Immunotherapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Allergy Immunotherapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Allergy Immunotherapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Allergy Immunotherapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Allergy Immunotherapy Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Allergy Immunotherapy Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy
Applications
  • Allergic Rhinitis
  • Allergic Asthma
  • Others
Companies covered
  • ALK-Abello
  • Stallergenes Greer
  • Merck
  • Allergy Therapeutics
  • HAL
  • Holister Stier
  • Leti

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Allergy Immunotherapy Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Allergy Immunotherapy Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Allergy Immunotherapy Market by Type
  6. 1.3.1 Subcutaneous Immunotherapy
  7. 1.3.2 Sublingual Immunotherapy
  8. 1.4 Global Allergy Immunotherapy Market Size by Type
  9. 1.4.1 Global Allergy Immunotherapy Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Allergy Immunotherapy Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Allergy Immunotherapy Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Allergy Immunotherapy Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Allergy Immunotherapy Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Allergy Immunotherapy Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Allergy Immunotherapy Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Allergy Immunotherapy Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Allergy Immunotherapy Industry Trends
  2. 2.2 Allergy Immunotherapy Industry Drivers
  3. 2.3 Allergy Immunotherapy Industry Opportunities and Challenges
  4. 2.4 Allergy Immunotherapy Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Allergy Immunotherapy Revenue (2021-2026)
  2. 3.2 Global Top Players by Allergy Immunotherapy Sales (2021-2026)
  3. 3.3 Global Top Players by Allergy Immunotherapy Price (2021-2026)
  4. 3.4 Global Allergy Immunotherapy Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Allergy Immunotherapy Major Company Production Sites & Headquarters
  6. 3.6 Global Allergy Immunotherapy Company, Product Type & Application
  7. 3.7 Global Allergy Immunotherapy Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Allergy Immunotherapy Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Allergy Immunotherapy Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Allergy Immunotherapy Tier 1, Tier 2, and Tier 3
4 Allergy Immunotherapy Regional Status and Outlook
  1. 4.1 Global Allergy Immunotherapy Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Allergy Immunotherapy Historic Market Size by Region
  3. 4.2.1 Global Allergy Immunotherapy Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Allergy Immunotherapy Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Allergy Immunotherapy Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Allergy Immunotherapy Forecasted Market Size by Region
  7. 4.3.1 Global Allergy Immunotherapy Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Allergy Immunotherapy Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Allergy Immunotherapy Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Allergy Immunotherapy by Application
  1. 5.1 Allergy Immunotherapy Market by Application
  2. 5.1.1 Allergic Rhinitis
  3. 5.1.2 Allergic Asthma
  4. 5.1.3 Others
  5. 5.2 Global Allergy Immunotherapy Market Size by Application
  6. 5.2.1 Global Allergy Immunotherapy Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Allergy Immunotherapy Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Allergy Immunotherapy Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Allergy Immunotherapy Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Allergy Immunotherapy Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Allergy Immunotherapy Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Allergy Immunotherapy Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Allergy Immunotherapy Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ALK-Abello
  2. 6.1.1 ALK-Abello Company Information
  3. 6.1.2 ALK-Abello Business Overview
  4. 6.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ALK-Abello Allergy Immunotherapy Product Portfolio
  6. 6.1.5 ALK-Abello Recent Developments
  7. 6.2 Stallergenes Greer
  8. 6.2.1 Stallergenes Greer Company Information
  9. 6.2.2 Stallergenes Greer Business Overview
  10. 6.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Stallergenes Greer Allergy Immunotherapy Product Portfolio
  12. 6.2.5 Stallergenes Greer Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Allergy Immunotherapy Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Allergy Therapeutics
  20. 6.4.1 Allergy Therapeutics Company Information
  21. 6.4.2 Allergy Therapeutics Business Overview
  22. 6.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Allergy Therapeutics Allergy Immunotherapy Product Portfolio
  24. 6.4.5 Allergy Therapeutics Recent Developments
  25. 6.5 HAL
  26. 6.5.1 HAL Company Information
  27. 6.5.2 HAL Business Overview
  28. 6.5.3 HAL Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 HAL Allergy Immunotherapy Product Portfolio
  30. 6.5.5 HAL Recent Developments
  31. 6.6 Holister Stier
  32. 6.6.1 Holister Stier Company Information
  33. 6.6.2 Holister Stier Business Overview
  34. 6.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Holister Stier Allergy Immunotherapy Product Portfolio
  36. 6.6.5 Holister Stier Recent Developments
  37. 6.7 Leti
  38. 6.7.1 Leti Company Information
  39. 6.7.2 Leti Business Overview
  40. 6.7.3 Leti Allergy Immunotherapy Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Leti Allergy Immunotherapy Product Portfolio
  42. 6.7.5 Leti Recent Developments
7 North America by Country
  1. 7.1 North America Allergy Immunotherapy Sales by Country
  2. 7.1.1 North America Allergy Immunotherapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Allergy Immunotherapy Sales by Country (2021-2026)
  4. 7.1.3 North America Allergy Immunotherapy Sales Forecast by Country (2027-2032)
  5. 7.2 North America Allergy Immunotherapy Market Size by Country
  6. 7.2.1 North America Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Allergy Immunotherapy Market Size by Country (2021-2026)
  8. 7.2.3 North America Allergy Immunotherapy Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Allergy Immunotherapy Sales by Country
  2. 8.1.1 Europe Allergy Immunotherapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Allergy Immunotherapy Sales by Country (2021-2026)
  4. 8.1.3 Europe Allergy Immunotherapy Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Allergy Immunotherapy Market Size by Country
  6. 8.2.1 Europe Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Allergy Immunotherapy Market Size by Country (2021-2026)
  8. 8.2.3 Europe Allergy Immunotherapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Allergy Immunotherapy Sales by Country
  2. 9.1.1 Asia-Pacific Allergy Immunotherapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Allergy Immunotherapy Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Allergy Immunotherapy Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Allergy Immunotherapy Market Size by Country
  6. 9.2.1 Asia-Pacific Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Allergy Immunotherapy Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Allergy Immunotherapy Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Allergy Immunotherapy Sales by Country
  2. 10.1.1 South America Allergy Immunotherapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Allergy Immunotherapy Sales by Country (2021-2026)
  4. 10.1.3 South America Allergy Immunotherapy Sales Forecast by Country (2027-2032)
  5. 10.2 South America Allergy Immunotherapy Market Size by Country
  6. 10.2.1 South America Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Allergy Immunotherapy Market Size by Country (2021-2026)
  8. 10.2.3 South America Allergy Immunotherapy Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Allergy Immunotherapy Sales by Country
  2. 11.1.1 Middle East and Africa Allergy Immunotherapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Allergy Immunotherapy Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Allergy Immunotherapy Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Allergy Immunotherapy Market Size by Country
  6. 11.2.1 Middle East and Africa Allergy Immunotherapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Allergy Immunotherapy Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Allergy Immunotherapy Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Allergy Immunotherapy Value Chain Analysis
  2. 12.1.1 Allergy Immunotherapy Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Allergy Immunotherapy Production Mode & Process
  7. 12.2 Allergy Immunotherapy Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Allergy Immunotherapy Distributors
  10. 12.2.3 Allergy Immunotherapy Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst